Author Question: Calvin's goals for the coming year include specific targets for increasing market share and quantity ... (Read 128 times)

drink

  • Hero Member
  • *****
  • Posts: 554
Calvin's goals for the coming year include specific targets for increasing market share and quantity of units shipped. If he succeeds, he will be handsomely rewarded.
 
  If he fails, he is likely to be replaced. Judging from this, it would appear that Calvin's employer subscribes to ________.
  A) the symbolic view of management
  B) the omnipotent view of management
  C) the impotent view of management
  D) the omniscient view of management

Question 2

Wendell interviews many middle-level managers and discovers that they share a different view of management. These individuals believe that external factors constrain managers' influence over outcomes.
 
  The mid-level managers have a(n) ________ view of management.
  A) traditional
  B) omnipotent
  C) reflective
  D) symbolic



thall411

  • Sr. Member
  • ****
  • Posts: 332
Answer to Question 1

Answer: B

Answer to Question 2

Answer: D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question


 

Did you know?

To prove that stomach ulcers were caused by bacteria and not by stress, a researcher consumed an entire laboratory beaker full of bacterial culture. After this, he did indeed develop stomach ulcers, and won the Nobel Prize for his discovery.

Did you know?

The oldest recorded age was 122. Madame Jeanne Calment was born in France in 1875 and died in 1997. She was a vegetarian and loved olive oil, port wine, and chocolate.

Did you know?

The average person is easily confused by the terms pharmaceutics and pharmacology, thinking they are one and the same. Whereas pharmaceutics is the science of preparing and dispensing drugs (otherwise known as the science of pharmacy), pharmacology is the study of medications.

Did you know?

There are approximately 3 million unintended pregnancies in the United States each year.

Did you know?

The first monoclonal antibodies were made exclusively from mouse cells. Some are now fully human, which means they are likely to be safer and may be more effective than older monoclonal antibodies.

For a complete list of videos, visit our video library